by KellerRohrback | Jun 28, 2017 | Class Actions |
Contact Us If you have taken Invokana, Invokamet, or Invokamet XR and have suffered from an amputation as a result, please contact us at (800) 776-6044, or email *protected email* Recent Invokana Clinical Trials Show Drug Doubles Risk of Amputation—Causing FDA to...
by KellerRohrback | Jun 19, 2017 | Consumer and Data Privacy Protection, Fiat Chrysler Resource Center |
Managing Partner Lynn Sarko Appointed to Plaintiffs’ Steering Committee for Fiat Chrysler Automobiles “EcoDiesel” Litigation June 19, 2017 Keller Rohrback’s managing partner Lynn Sarko has been appointed to serve on the Plaintiffs’ Steering Committee in...
by KellerRohrback | Jun 16, 2017 | Class Actions |
Keller Rohrback L.L.P. Takes On Drug Companies and Pharmacy Benefit Managers for driving up the cost of Diabetes Drugs and Products Following its filing of a class action challenging soaring insulin prices, Keller Rohrback L.L.P. has filed three more lawsuits against...
by KellerRohrback | Jun 16, 2017 | Class Actions, Consumer and Data Privacy Protection |
Keller Rohrback L.L.P. Investigates Reports that Wells Fargo Charged Customers Millions in Improper Mortgage Rate Lock Fees UPDATE, Sept. 18, 2017: On August 28th, 2017 Keller Rohrback L.L.P. filed the first class action lawsuit relating to Wells Fargo’s alleged...
by KellerRohrback | Jun 9, 2017 | Firm News |
Fifteen Keller Rohrback Lawyers Named 2017 Washington Super Lawyers & Rising Stars Keller Rohrback is proud to announce that fifteen of our attorneys have been named Super Lawyers or Rising Stars for 2017. Peer nominated and reviewed, then independently...
